JP2007505894A5 - - Google Patents

Download PDF

Info

Publication number
JP2007505894A5
JP2007505894A5 JP2006526810A JP2006526810A JP2007505894A5 JP 2007505894 A5 JP2007505894 A5 JP 2007505894A5 JP 2006526810 A JP2006526810 A JP 2006526810A JP 2006526810 A JP2006526810 A JP 2006526810A JP 2007505894 A5 JP2007505894 A5 JP 2007505894A5
Authority
JP
Japan
Prior art keywords
active ingredient
delivery system
drug delivery
oral drug
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006526810A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007505894A (ja
JP5666075B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2004/000192 external-priority patent/WO2005039481A2/en
Publication of JP2007505894A publication Critical patent/JP2007505894A/ja
Publication of JP2007505894A5 publication Critical patent/JP2007505894A5/ja
Application granted granted Critical
Publication of JP5666075B2 publication Critical patent/JP5666075B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

JP2006526810A 2003-09-19 2004-06-30 経口薬送達システム Expired - Lifetime JP5666075B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN987MU2003 2003-09-19
IN987/MUM/2003 2003-09-19
PCT/IN2004/000192 WO2005039481A2 (en) 2003-09-19 2004-06-30 Oral drug delivery system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014210770A Division JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Publications (3)

Publication Number Publication Date
JP2007505894A JP2007505894A (ja) 2007-03-15
JP2007505894A5 true JP2007505894A5 (enExample) 2012-06-14
JP5666075B2 JP5666075B2 (ja) 2015-02-12

Family

ID=34509346

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006526810A Expired - Lifetime JP5666075B2 (ja) 2003-09-19 2004-06-30 経口薬送達システム
JP2014210770A Pending JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014210770A Pending JP2015038126A (ja) 2003-09-19 2014-10-15 経口薬送達システム

Country Status (17)

Country Link
US (2) US8163306B2 (enExample)
EP (1) EP1663175B1 (enExample)
JP (2) JP5666075B2 (enExample)
KR (1) KR101164881B1 (enExample)
CN (1) CN1856299B (enExample)
AP (1) AP2006003602A0 (enExample)
AT (1) ATE551051T1 (enExample)
AU (2) AU2004283565C1 (enExample)
BR (1) BRPI0414305A (enExample)
CA (1) CA2543353C (enExample)
EA (1) EA013106B1 (enExample)
IL (1) IL174396A (enExample)
NZ (1) NZ546543A (enExample)
PL (2) PL1663175T3 (enExample)
UA (1) UA85850C2 (enExample)
WO (1) WO2005039481A2 (enExample)
ZA (1) ZA200602276B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156900A1 (en) * 2001-04-10 2004-08-12 Shanghvi Dilip Shantilal Time pulsed release composition
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
EP1663175B1 (en) * 2003-09-19 2012-03-28 Sun Pharma Advanced Research Company Limited Oral drug delivery system
EP1909770B1 (en) * 2005-02-22 2013-03-20 Sun Pharmaceutical Industries Limited Oral controlled release composition containing levetiracetam
EP1858493A4 (en) * 2005-03-14 2010-12-01 Sun Pharmaceutical Ind Ltd SYSTEM FOR ORAL ADMINISTRATION OF MEDICINAL PRODUCTS
EP1898886B1 (en) 2005-07-01 2019-09-04 Rubicon Research Pvt Ltd. Novel sustained release dosage form
WO2007072495A2 (en) * 2005-11-03 2007-06-28 Sun Pharmaceutical Industries Limited Coated tablets having prolonged gastric retention
WO2009087663A2 (en) * 2007-11-30 2009-07-16 Sun Pharmaceutical Industries Ltd. Oral controlled release coated tablet
CN102026628A (zh) * 2008-02-15 2011-04-20 太阳医药高级研发有限公司 具有降低崩裂效果的口服控释片剂
JP2012528799A (ja) * 2009-06-02 2012-11-15 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
US10485770B2 (en) * 2009-12-21 2019-11-26 Aptapharma, Inc. Functionally-coated multilayer tablets
FR2985177B1 (fr) * 2012-01-02 2016-04-01 Oreal Composition cosmetique solide aqueuse comprenant de l'alkylcellulose, au moins deux huiles non volatiles et au moins deux agents tensioactifs
FR2985179B1 (fr) * 2012-01-02 2020-05-15 L'oreal Composition cosmetique aqueuse solide comprenant de l'alkylcellulose, au moins deux huiles non volatiles et au moins deux agents tensioactifs
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
US11554114B2 (en) 2017-03-31 2023-01-17 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredients
IT201800011123A1 (it) * 2018-12-14 2020-06-14 Dpl Pharma S P A Composizioni farmaceutiche orali solide per la somministrazione cronotropica di sartani
BR112023001529A2 (pt) * 2020-07-28 2023-04-11 Novelstar Pharmaceuticals Inc Nova forma de dosagem de liberação estendida gastroretentiva

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2140687A (en) * 1938-02-04 1938-12-20 Claude W Mcqueen Tractor drive take-off
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4693896A (en) 1985-10-07 1987-09-15 Fmc Corporation Ethylcellulose-coated, gastric-disintegrable aspirin tablet
IT1188212B (it) 1985-12-20 1988-01-07 Paolo Colombo Sistema per il rilascio a velocita' controllata di sostanze attive
US5271946A (en) * 1988-04-20 1993-12-21 Asta Pharma Aktiengesellschaft Controlled release azelastine-containing pharmaceutical compositions
IT1237904B (it) 1989-12-14 1993-06-18 Ubaldo Conte Compresse a rilascio a velocita' controllata delle sostanze attive
ATE183642T1 (de) * 1991-10-04 1999-09-15 Yoshitomi Pharmaceutical Tablette mit verzögerter freisetzung
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
BR9307859A (pt) 1993-05-15 1996-01-09 Boehringer Mannheim Gmbh Comprimido com biodisponibilidade aperfeiçoada que contérn ácido
IT1264517B1 (it) 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
US6322819B1 (en) * 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
JP2001055322A (ja) * 1999-08-18 2001-02-27 Tanabe Seiyaku Co Ltd パルス放出型製剤
US6332819B1 (en) * 1999-10-08 2001-12-25 Jerrold K. Emmons Object retrieval device used in water
US6720005B1 (en) 2000-07-07 2004-04-13 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Coated, platform-generating tablet
AU2002320360B2 (en) 2001-07-10 2005-05-26 Teva Pharmaceutical Industries Ltd. Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
ITMI20020514A1 (it) 2002-03-12 2003-09-12 Jagotec Ag Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
ITMI20020515A1 (it) 2002-03-12 2003-09-12 Jagotec Ag Sistema per il rilasco controllato di uno o piu' principi attivi
US20060210633A1 (en) 2003-04-03 2006-09-21 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US7314640B2 (en) 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
EP1663175B1 (en) 2003-09-19 2012-03-28 Sun Pharma Advanced Research Company Limited Oral drug delivery system

Similar Documents

Publication Publication Date Title
Bussemer et al. A pulsatile drug delivery system based on rupturable coated hard gelatin capsules
US8470367B2 (en) Oral drug delivery system
JP2011512349A (ja) 経口放出制御錠剤
JPH0269414A (ja) 持続的制御放出パターンを有する生物活性物質コーティング剤
RU2006143540A (ru) Содержащие варденафил лекарственные формы с регулируемым высвобождением действующего вещества
AU780045B2 (en) Dosage forms having a barrier layer to laser ablation
US20130039967A1 (en) Oral dosage forms
CA2601800C (en) Oral drug delivery system
US10226428B2 (en) Oral drug delivery system
KR101048925B1 (ko) 조절 약물 방출을 위한 경구 투여 제형
CA2490412A1 (en) Oral dosage from comprising a liquid active agent formulation and controlling release thereof by an expandable osmotic composition
US10213387B2 (en) Oral drug delivery system
CA3165394C (en) Soluble rear layer for oral thin film
TH103546A (th) ระบบการนำส่งยาทางปาก
MXPA06002994A (en) Oral drug delivery system
MXPA06001197A (en) Osmotic engine and dosage form for controlled release of a liquid active agent formulation